Join a Clinical Trial
Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.
Clinical Trial Details
A Study of U3-1402 in Subjects With Metastatic Breast Cancer
Complete Title: A Phase II Study of U3-1402 in Patients with Metastatic Breast Cancer
Trial Phase: II
Investigator: William Gwin
This study is to evaluate safety and efficacy of an antibody drug conjugate U3-1402 in patients with metastatic breast cancer (MBC) who have received no prior anti-HER2 therapy.
Keywords:
- Breast Cancer
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Contact Us
If you are seeking to schedule an appointment, we are here to help. You can either call us or fill out our online appointment request form.
Adult
II
William Gwin
RG1121512
NCT04699630
A Phase II Study of U3-1402 in Patients with Metastatic Breast Cancer
Breast Cancer